OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)

Clinical trial NCT04389229 · WITHDRAWN

Trial details

NCT number: NCT04389229
Sponsor: Immetacyte Ltd
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Metastatic

Start date: 2020-07-01
Primary completion: 2023-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.